Zopiclone, sleep and health-related qual
β
F. Goldenberg; I. Hindmarch; C. R. B. Joyce; M. Le Gal; M. Partinen; C. Pilate
π
Article
π
1994
π
John Wiley and Sons
π
English
β 940 KB
458 insomniac patients participated in a multinational, randomised, double blind, parallel groups study of zopiclone 7.5 mg versus placebo. Patients received the drug or placebo nightly for 14 days and for a further six weeks on demand. Sleep characteristics and Quality of Life measures were assesse